112 related articles for article (PubMed ID: 6592359)
1. Synthesis and in vitro biological evaluation of N-[(5-amino-1-beta-D-ribofuranosyl-1H-imidazol-4-yl)carbonyl]-3- (hydroxynitrosamino)-L-alanine (L-alanosine AICO ribonucleoside).
Strazzolini P; Malabarba A; Ferrari P; Grandi M; Cavalleri B
J Med Chem; 1984 Oct; 27(10):1295-9. PubMed ID: 6592359
[TBL] [Abstract][Full Text] [Related]
2. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase.
Tyagi AK; Cooney DA
Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071
[TBL] [Abstract][Full Text] [Related]
3. Determinants of the toxicity of L-alanosine to various organs of the mouse.
Tyagi AK; Thake DC; McGee E; Cooney DA
Toxicology; 1981; 21(1):59-69. PubMed ID: 7281196
[TBL] [Abstract][Full Text] [Related]
4. Nonenzymatic synthesis of 5-aminoimidazole ribonucleoside and recognition of its facile rearrangement.
Groziak MP; Bhat B; Leonard NJ
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7174-6. PubMed ID: 3174626
[TBL] [Abstract][Full Text] [Related]
5. A novel synergistic effect of alanosine and guanine on adenine nucleotide synthesis in mammalian cells. Alanosine as a useful probe for investigating purine nucleotide metabolism.
Gupta RS
J Cell Physiol; 1980 Aug; 104(2):241-8. PubMed ID: 7410492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of N6-(n-alkylureido)purine ribonucleosides and their 5'-phosphates.
Hong CI; Mittelman A; Chheda GB
J Pharm Sci; 1978 Apr; 67(4):569-71. PubMed ID: 565402
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of 6-azacadeguomycin and certain 3,4,6-trisubstituted pyrazolo[3,4-d]pyrimidine ribonucleosides.
Petrie CR; Cottam HB; McKernan PA; Robins RK; Revankar GR
J Med Chem; 1985 Aug; 28(8):1010-6. PubMed ID: 4020823
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of adenylosuccinate lyase by L-alanosyl-5-aminoimidazole-4-carboxylic acid ribonucleotide (alanosyl-AICOR).
Casey PJ; Lowenstein JM
Biochem Pharmacol; 1987 Mar; 36(5):705-9. PubMed ID: 3827951
[TBL] [Abstract][Full Text] [Related]
9. Identification of gene expression profiles predicting tumor cell response to L-alanosine.
Efferth T; Gebhart E; Ross DD; Sauerbrey A
Biochem Pharmacol; 2003 Aug; 66(4):613-21. PubMed ID: 12906926
[TBL] [Abstract][Full Text] [Related]
10. Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells.
Li W; Su D; Mizobuchi H; Martin DS; Gu B; Gorlick R; Cole P; Bertino JR
Oncol Res; 2004; 14(7-8):373-9. PubMed ID: 15301428
[TBL] [Abstract][Full Text] [Related]
11. Synthesis properties of the naturally occurring N-[(9-beta-D-ribofuranosylpurin-6-yl)-N-methylcarbamoyl]-L-threonine (mt-6A) and other related synthetic analogs.
Dutta SP; Hong CI; Murphy GP; Mittelman A; Chheda GB
Biochemistry; 1975 Jul; 14(14):3144-51. PubMed ID: 1148194
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of fluorine-substituted 4-amino-2(1H)-pyridinones and their nucleosides. 3-Deazacytosines.
McNamara DJ; Cook PD
J Med Chem; 1987 Feb; 30(2):340-7. PubMed ID: 3806615
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolopyrimidine nucleosides. 18. Synthesis and chemotherapeutic activity of 4-amino-7-(3-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (3'-deoxysangivamycin) and 4-amino-7-(2-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (2'-deoxysangivamycin).
Maruyama T; Wotring LL; Townsend LB
J Med Chem; 1983 Jan; 26(1):25-9. PubMed ID: 6827526
[TBL] [Abstract][Full Text] [Related]
14. 4-Amino-3-(2,3,5-tri-O-benzyl-beta-D-ribofuranosyl)-5-pyrazole-carb oni trile. Synthesis and conversion into a sugar-blocked 5,7-disubstituted formycin analog.
Rosowsky A; Ghoshal M; Solan VC
Carbohydr Res; 1988 May; 176(1):47-58. PubMed ID: 3401884
[TBL] [Abstract][Full Text] [Related]
15. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL
Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines related to formycin prepared via ring closure of a 1,2,4-triazine precursor.
Ramasamy K; Ugarkar BG; McKernan PA; Robins RK; Revankar GR
J Med Chem; 1986 Nov; 29(11):2231-5. PubMed ID: 3783585
[TBL] [Abstract][Full Text] [Related]
17. Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.
Graff JC; Plagemann PG
Cancer Res; 1976 Apr; 36(4):1428-40. PubMed ID: 177207
[TBL] [Abstract][Full Text] [Related]
18. Alanosine (UCSD).
Yu J
Curr Opin Investig Drugs; 2001 Nov; 2(11):1623-30. PubMed ID: 11763167
[TBL] [Abstract][Full Text] [Related]
19. A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancer.
Creagan ET; O'Connell MJ; Kovach JS
Cancer; 1983 Aug; 52(4):615-8. PubMed ID: 6861099
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cell growth inhibition, and antitumor screening of 2-(p-n-butylanilino)purines and their nucleoside analogues.
Wright GE; Dudycz LW; Kazimierczuk Z; Brown NC; Khan NN
J Med Chem; 1987 Jan; 30(1):109-16. PubMed ID: 3806587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
